Listening
Episodes
One search box across the whole catalog, titles and show notes alike. It earns its keep when you half-remember a case, a device or a name and want the conversation it came up in.
5,508 episodes · 33 shows
Morning Brief — Thursday, October 15, 2026
FDA approves two-level use of Centinel Spine's prodisc C Nova, making three of Centinel's four cervical discs labeled for one or two contiguous levels · Zimmer Biomet and THINK Surgical sign a multi-year extension of their exclusive distribution deal for a Persona-compatible version of the TMINI handheld knee robot · Patient-specific spine at NASS: Carlsmed starts the full U.S. launch of its aprevo lumbar bi-lateral posterior system as Globus previews its FDA-cleared SCRIPT patient-specific platform · JBJS: 791 anatomic total shoulders from Florida Orthopaedic Institute show 96% implant survival at 10 years, but 69.5% of shoulders at the patient-acceptable threshold
Morning Brief — Monday, October 12, 2026
DePuy Synthes signs a U.S. sales agency agreement with SMAIO for the KEOPS-4ME planning platform and patient-specific K-ROD rods · FDA grants De Novo to Brixton Biosciences' ReneuRx (Neural Ice), an injectable cold slurry for knee OA pain, creating a new Class II category · Anesthesia & Analgesia RCT, 180 PLIF patients: deep neuromuscular block cut 3-month chronic postsurgical pain from 34.8% to 19.1% versus moderate block; no significant difference at 6 months · J Neurosurg Spine, CSM-Protect secondary analysis: dysphagia after multilevel anterior surgery for cervical myelopathy peaked at 68.6% and was still 36.4% at one year
Morning Brief — Friday, October 9, 2026
CMS posts the CJR-X participant list: 2,217 hospitals in a mandatory 90-day hip, knee and ankle bundle starting January 1, 2028 · SurGenTec takes an exclusive license to Allevion Medical's Vantage, a fully disposable lumbar decompression kit cleared in March as K252546 · FDA 510(k) clears Mass General's GSPE Spacer, a gentamicin-loaded UHMWPE temporary knee spacer for two-stage PJI; commercial license still pending · JBJS Yale RCT in primary THA: anterior QLB plus LFCN block vs periarticular/local infiltration, both with dual glucocorticoids, no difference in day-one opioids
Morning Brief — Thursday, October 8, 2026
Centinel Spine files publicly for a NYSE IPO under CNTL: first-half 2026 revenue $85.2M (+42%), net income $10.2M, pure-play prodisc total disc replacement · MRI2CT announces FDA 510(k) clearance for NextMR Spine, cloud software that generates 3D lumbar spine and sacrum bone images from standard MRI, entering a category MRIguidance's BoneMRI has held since 2022 · Smith+Nephew launches CARTIHEAL AGILI-C in 12 European markets ahead of the ICRS Summit in Porto, on five-year RCT data against microfracture and debridement · KSSTA, Bridge registry two-year results for Miach's BEAR implant: 5.6% ipsilateral ACL retear, none in year one, but 18.9% overall reoperation (28.0% original vs 7.5% modified technique)
Morning Brief — Wednesday, October 7, 2026
icotec's CMORE CT carbon/PEEK cervicothoracic system gets a Medicare new technology add-on payment, up to $60,905 per case, for fusion use only · Stryker names Spencer Stiles CEO effective January 1, 2027; Kevin Lobo becomes Executive Chair · Neurosurgical Focus, pooled analysis of two randomized trials (211 patients): wound dehiscence 0% after biportal endoscopic vs 8.7% after microscopic single-level lumbar decompression
Morning Brief — Tuesday, October 6, 2026
Pacira licenses EXPAREL to Molteni Farmaceutici for the EU and UK; Italy, Germany, Austria and Poland first, first commercial sale expected in 2027 · Spine RCT, 70 patients with grade III-IV spondylolisthesis: extending L4-S1 fixation to S2 or S2AI cut S1 screw breakage from 66% to zero and improved 36-month pain and ODI · Spine, Houston Methodist: screening ligamentum flavum at lumbar decompression found transthyretin amyloid in 20% of 50 selected patients
Morning Brief — Monday, October 5, 2026
AMA CPT Editorial Panel votes a Category I code for posterior vertebral column arthroplasty, covering Premia Spine's TOPS facet replacement, effective January 1, 2028 · J Neurosurg Spine, Washington State Spine COAP registry: intrawound antibiotics not associated with fewer surgical site infections across 24,015 instrumented spine cases · CORR target trial emulation of 4,564 Japanese periprosthetic hip fractures: no clear 30- or 90-day mortality difference between surgery within two days and surgery on days three to ten
Morning Brief — Friday, October 2, 2026
PearlMatrix P-15 peptide bone graft's Medicare new technology add-on payment goes live October 1 — TLIF use only, capped at $3,380, alongside INFUSE's $4,396.60 TLIF add-on · Tenon Medical takes the 3D-printed titanium lateral screw in its SImmetry+ SI joint fusion system to full commercial launch after a ~$1.2M alpha · JBJS: revision hip and knee volume across 17 registry countries projected to rise ~36% by 2060, led by the US and China · BMJ, UK National Joint Registry target trial emulation: robotic and conventional hips and knees show equal five-year implant survival; robotic hips had about half the malposition-related revisions
Morning Brief — Thursday, October 1, 2026
Terumo Neuro signs to acquire Arsenal Medical and its investigational NeoCast liquid embolic for middle meningeal artery embolization, now in a pivotal trial head to head against Onyx · Sharp HealthCare becomes a strategic equity partner in the DISC Surgery Center at Carlsbad, a spine-heavy ASC, three months after taking over Tri-City Medical Center · Two rib fixation entrants in one week: Chest Wall Innovations launches PC Fix, with an intrathoracic PEEK option, and GMReis announces 510(k) clearance for VersaLock rib and sternum plates · NEJM publishes TRIUMPH-1: retatrutide cut weight by up to 25% at 80 weeks and reduced WOMAC knee pain 1.6 to 1.8 points more than placebo in 574 participants with knee osteoarthritis
Morning Brief — Wednesday, September 30, 2026
Carlsmed appoints former ZimVie CFO Richard Heppenstall as chief financial officer and reaffirms 2026 revenue guidance of $74 to $78 million ahead of the October 1 aprevo payment policy · VB Spine receives FDA Breakthrough Device Designation for ScolimiR-3D, a six-microRNA blood test to predict adolescent idiopathic scoliosis progression · Anesthesiology: in 258,624 Ontario hip and knee arthroplasties, a new extended-release opioid prescription at discharge was associated with more persistent opioid use, readmissions and ED visits · OTA 2026 randomized trial: local aqueous tobramycin added to IV antibiotics did not reduce infection in 569 open extremity fractures
Morning Brief — Tuesday, September 29, 2026
FDA issues draft guidance on premarket submissions for robotically-assisted surgical devices; orthopedic (OLO) and neurological (HAW) stereotaxic systems are explicitly out of scope; comments due November 24, 2026 · Avesi Partners invests in New Age Medical, a St. Louis spine supply hub linking 85+ manufacturers, 100+ reps, 200+ hospitals/ASCs and 350+ surgeons, to fund expansion, new specialties and M&A · SI-BONE receives FDA 510(k) clearance for iFuse Granite Onyx, aimed at screw loosening at the UIV and LIV of spinal fusion constructs in low-density bone · HSS cohort at EBJIS-MSIS 2026: extended oral antibiotics after two-stage TKA reimplantation did not reduce PJI-related reoperation in 2,181 patients
Morning Brief — Monday, September 28, 2026
Spine Journal: in 18,914 matched single-level P/TLIFs, rhBMP-2 added $4,543 and 14% to the index encounter with no significant difference in readmission, revision or two-year costs · Precision Neuroscience closes an oversubscribed $250M Series D for its Layer 7 surface brain-computer interface · UPMC's CLEAR rapid exchange protocol for recalcitrant PJI: 10% failure versus 60% for historical repeat two-stage controls (EBJIS-MSIS 2026) · ICSES 2026 meta-analysis: PRP no better than placebo for lateral epicondylitis across six RCTs and 355 patients
Morning Brief — Friday, September 25, 2026
Catalyst OrthoScience joins Redefine Surgery as founding shoulder partner, off an oversubscribed $10M surgeon-backed pre-seed round · SIGNUS USA's COSY occipitocervical-thoracic fixation system completes its first U.S. surgery · SI-BONE recalls 98 iFuse TORQ implants over a sterile-packaging failure, recommends FDA Class II classification
Morning Brief — Wednesday, September 23, 2026
Smith+Nephew clears the LANDMARK Total Knee System and completes its first cases, with a fully 3D-printed CONCELOC femur built around CORI · Enovis becomes the first industry sponsor to fund two AAOS registries at once, adding the Shoulder & Elbow Registry to AJRR through 2027 · Xenix Medical clears the Riva Anchor spinopelvic fixation system with a NanoACTIV surface, going after SI-BONE's hold on the base of long deformity constructs · Clinical Orthopaedics publishes FNF-ON8, a five-variable score for osteonecrosis after femoral neck fracture fixation that outperforms the Garden classification
Morning Brief — Tuesday, September 22, 2026
JBJS: a Houston private practice audits three years of CPT 22-modifier claims — 71.7% approved, 7.7% more money, and up to 77% longer to get paid · ORTHOWORLD's 2026 spine market analysis: an $11B market growing ~3%, with Medtronic and Globus at a combined 43% and nobody else above 8% · Smith+Nephew brings the acquired Tendon Seam cuff system, a new knotless anchor and both-sides handheld shoulder robotics to ICSES 2026 — contesting Zimmer Biomet's May 'first' claim · ESSKA and the European Shoulder Associates publish their formal consensus on partial-thickness posterosuperior cuff tears: nonsurgical first, one Grade A recommendation, and Grade B support for PRP · Five-year randomized subgroup from Lyon: 16.4% graft failure after isolated BPTB versus 4.8% for hamstring plus anterolateral ligament reconstruction in patients under 25
Morning Brief — Monday, September 21, 2026
Two bunion datasets out of AOFAS 2026 pull against each other: Treace's five-year ALIGN3D Lapiplasty results, and an HSS series where MIS Lapidus matched open Lapidus on PROMIS at one year · Zimmer Biomet takes the both-sides ROSA Shoulder System to ICSES 2026 in Vancouver, where Stryker and Enovis are the other top-tier sponsors · Fusion Orthopedics launches the FibFix fibula nail into AOFAS and OTA, going after a small intramedullary category held by Acumed and Arthrex · Clinical Orthopaedics and Related Research publishes a methodological audit finding the synovial leukocyte count and differential are poor standalone rule-in tests for PJI, against the 2025 meta-analysis behind the Unified PJI Criteria
Morning Brief — Friday, September 18, 2026
Mindray launches the SV70 non-invasive ventilator into the fleet-replacement hole Philips left when it exited hospital ventilation · Stryker brings Prophecy patient-specific planning to the Incompass total ankle, plus a Hoffmann LRF smartHEX frame with a patient-facing app, at AOFAS 2026 · SIGNUS USA completes the first US implantation of COSY, its posterior occipito-cervico-thoracic fixation system, with up to 70 degrees of screw angulation · Onkos releases the ELEOS Total Femoral Adapter with NanoCept, the first implant coated at its own new New Jersey facility, with human infection-reduction data still pending a Section 522 study
Morning Brief — Thursday, September 17, 2026
CMS expands the ACCESS digital chronic-care model: four new tracks from spring 2027 and musculoskeletal pain support past the first 12 months · Federal Circuit affirms Globus Medical's noninfringement win over three Moskowitz Family spinal implant patents in a precedential opinion · Synergy Spine presents two-year ALIGN-1L IDE data at SMISS: 87.1% composite clinical success for the one-level Synergy Disc versus 56.6% for matched ACDF controls
Morning Brief — Wednesday, September 16, 2026
HHS OIG: Medicare Advantage plans under-screen out-of-network equipment suppliers, who bill seven times more for orthotics than enrolled suppliers · Zimmer Biomet proposes cutting up to 580 jobs at its Winterthur, Switzerland plant — most of the site · Paradromics says the first Connexus BCI participant is using the implant for real-time, self-generated speech · Arthritis Care & Research: fully automated MRI cartilage segmentation separates knees headed for replacement at least as well as expert manual analysis
Morning Brief — Tuesday, September 15, 2026
Bloomberg and WSJ: J&J is in talks to sell DePuy Synthes to Apollo Global Management for close to $20 billion · AAOS files its CY2027 fee schedule comment letter on the deadline: keep 2026 work RVUs for primary hip, knee and shoulder arthroplasty and drop the 50% same-day E/M cut · ACR posts its 2026 osteoarthritis guideline: strong against PRP and stem cell injections in knee and hip, conditional yes to GLP-1 receptor agonists in knee OA with obesity
Morning Brief — Monday, September 14, 2026
SI-BONE recalls 98 iFuse TORQ implants over tube packaging that may not hold a sterile barrier; two already implanted · Medtronic's Stealth AXiS does its first clinical cases in Europe, starting with complex spine revision · Mayo Clinic: about 30% of knee MACI biopsies proceed to implantation at a mean 4.3 years
Morning Brief — Friday, September 11, 2026
FDA puts its most serious recall classification on Boston Scientific's Infinion CX spinal cord stimulator leads after 1,081 serious injuries · Shoulder Innovations clears the N-22 humeral head for metal-hypersensitive anatomic total shoulder and ships the same day · Shoulder Innovations takes exclusive US upper-extremity rights to ALM Ortho's patient-matched titanium implants · restor3d launches MyFit, a patient-facing layer whose real payload is a 2,250-patient patient-specific implant registry · Biocomposites takes combination-antibiotic STIMULAN biofilm data to EBJIS-MSIS in Porto
Morning Brief — Thursday, September 10, 2026
Medacta's H1 2026: 9.7% constant-currency growth, but North America is the slowest region and gross margin fell 310 basis points · ArthroTAK's sutureless PEEK anchor clears FDA for expanded indications, and its first target is lateral extra-articular tenodesis · Journal of Spine Surgery publishes cadaveric accuracy data on OnPoint's augmented reality guidance: 1.1 mm positional, 1.3 degrees angular across 80 pedicle screws · Bone Biologics doubles its Australian NB1 sites to six, aiming to finish enrollment in the rhNELL-1 TLIF pilot by year end
Morning Brief — Tuesday, September 8, 2026
AMA and more than 150 organizations ask CMS to withdraw the modifier-25 payment cut before the September 14 comment deadline · AMA backs site-neutral imaging in the CY2027 outpatient rule but objects to $260M leaving Part B with nothing coming back · Kinomatic launches Kinect, an implant-independent planning platform whose real product is the joint-replacement data lake underneath it · Globus Medical takes Excelsius3D into the EU and UK on a CE mark, five years after its FDA clearance